It's easy to see why, then, scientists have turned their attention to stem cell research. With stem cell technology, new cells of the needed type could be produced and used to replace damaged ones, and thus regenerate tissues and organs in patients.
WHAT DOES THE LIVER DO?
The liver is large reddish-brown organ that sits to the right side of the belly. Its job is to filter the blood coming from the digestive tract and to break down and remove unwanted materials. It also produces bile -a substance that helps the small intestine break down and absorb fats, cholesterol, and some vitamins. There are many other functions that the liver performs
IMAGINE THIS SCENAR IO
Alex is 12. He has a condition that is causing severe damage to his liver. To treat him, and get him back on his feet again, he needs a full liver transplant. However, there aren't enough healthy livers available, and he has been waiting for one for over three months. Alex is of Asian descent, which means there are fewer compatible donors available. How terrifying must that be? Imagine, though, if new, healthy liver tissue could be made in the lab. Scientists have discovered that this is indeed possible -with stem cell technology.
According to the UK's Foundat ion for Li ve r Re se arch, 1 in 10 pe ople will h ave a problem wi th the ir li ve r.
As of Novembe r 2018, 346 pe ople are wai t ing for a li ve r t ransplan t; 36 of which are unde r 18, according to the UK's Nat ion al He al th Se r v ice (NHS).
For adul ts, the ave rage wai t ing t ime for a li ve r t ransplan t in the UK is 135 days; for childre n this is 73 days (NHS). As you can imagine, liver damage is bad news for the body. The damage reduces the liver's capacity to perform necessary functions. This negatively impacts a patient's health, and can result in death. It's vital, therefore, that liver disease is treated and that this is accompanied by the necessary lifestyle changes such as giving up or reducing alcohol intake, eating a balanced diet and exercising regularly.
GRO WIN G HUM AN
HOW IS SEVERE LIVER DISEASE NORMALLY TREATED? Some medications and surgical procedures may help. However, in cases of severe damage, a full liver transplant is the only option. The problem is, livers are in short supply. In some areas, suitable donors are unavailable. The shortfall of suitable donors can also be worse for some patients depending on their ethnicity and the country in which they reside. Using stem cells to grow liver tissue in the lab, therefore, is seen as a possible solution to this problem.
HOW DO YOU MAKE NEW LIVER CELLS?
Making new cells in the lab is a complicated process. "In a nutshell," Dave explains, "making new cells in the lab involves feeding the stem cells different factors and nutrients that are involved in human development".
Depending on the conditions the stem cells are exposed to, scientists can make different types of cells, such as hepatocytes, the main
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Dave's research focuses on using stem cells to engineer tissue types and organs in the lab. For example, he has been working with pluripotent stem cells to create liver cells and tissue, with the goal of developing alternative treatment options to full liver transplants.
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FUNDERS cell type of the liver "Our interest is in the liver and, in particular, producing hepatocytelike cells," says Dave. "Our cells are similar to human adult liver cells but possess major foetal and neonatal attributes. So, we call them hepatocyte-like cells, and not hepatocytes, because they're not fully mature."
In the lab, Dave and his team use a material known as 'agarose' in which liver spheres form.
Agarose is a material that is extracted from seaweed and used to make gels. These gels, when set, are the perfect growth medium. "Cells don't bind to the agarose, meaning that they attach to each other and self-assemble into clumps," says Dave. And it's these clumps of new, healthy tissue that could be implanted into a patient in the future.
HOW LONG WILL IT BE BEFORE LAB-GROWN LIVERS ARE USED TO TREAT PATIENTS?
Research by Dave and his team has found that their specially-designed liver tissue implants supported liver function in mice with a certain type of liver disease -an advance that could be the first step towards developing liver tissue implants for people.
For now, the researchers are focusing on being able to transplant small fragments of liver tissue into a patient until a suitable donor organ becomes available for transplant (rather than growing a full human liver). And the team are in the process of working with industry and writing grants to move towards this. Reflecting on current progress, Dave commented, "What I can say is this -we have a stable and renewable product we can apply to study human liver biology in the lab and hopefully one day use in the clinic."
But, before any new therapy or intervention can be used on people, scientists have to show that that their work could become a reality -a process known as proof of concept -and conduct clinical trials. Dave hopes to have this proof of concept within the next five years.
Evaluation of hepatic markers at gene and protein level
Tissue engineering is an exciting field of study and many scientists and medical professionals feel it has great potential to treat numerous diseases. We ask Dave to tell us more about it.
WHAT IS TISSUE ENGINEER ING AND HOW DOES IT FIT WITHIN THE WIDER CONTEXT OF STEM CELL RESEARCH AND REGENERA TIVE MEDICINE?
Tissue engineering is the field of research that combines cells with biologic and synthetic components to build functional units of tissue. This allows the researcher to study tissue assembly, function, health and disease 'in the dish'. It may also be later deployed within a clinical setting to treat loss of function or disease.
IS REGENERA TIVE MEDICINE BEING USED IN HOSPITALS NOW?
Yes, bone marrow transplant is a good example of stem cell therapy. With regard to pluripotent stem cell-derived therapies, they have been used clinically to successfully correct macular degeneration and will be used this year in trials aimed at treating Parkinson's disease.
IF RESEARCH SUCH AS YOURS WON'T BE IN EVERYDAY USE FOR SO MANY YEARS, WHY GET EXCITED ABOUT IT?
Our ability to make human tissue from any individual -subject to consent and ethics processes -enables us to study their characteristic s 'in a dish'. This allows us to better understand disease and tailor make treatments for that disease. That's exciting because the technology will provide us with great opportunities to treat tissue damage and degenerative diseases. These technologies will transform medicine as we move through the next 10-20 years. My advice would be to follow what interests you most. In this way you'll not feel like you're just working to an end. Rather, you'll feel like you're following your curiosity. This will make you more motivated.
ASK DR DAV E HAY
Development and characterisation of a sub-cutaneous implant
Development and characterisation of a sub-cutaneous implant I wanted to be a footballer when I was younger. The problem was, I wasn't very good at it! But I always enjoyed biology and chemistry at school, and this led me to study biochemist ry at university.
